Phosphodiesterase-5 inhibitor tadalafil acts on endothelial progenitor cells by CXCR4 signalling

Current Drug Delivery

Volumn 7, Issue 4, 2010, Pages 274-282

  Foresta, Carlo ^a   de Toni, Luca ^a   Magagna, Sabina ^a   Galan, Alessandro ^b   Garolla, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b S ANTONIO HOSPITAL   (Italy)

Author keywords

Angiogenesis; cGMP; CXCR4; Endothelial progenitor cells; PDE5; Tadalafil

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYCLIC GMP; PHOSPHODIESTERASE V INHIBITOR; PLERIXAFOR; TADALAFIL;

ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL;

ADULT; CARBOLINES; CELLS, CULTURED; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; ENDOTHELIAL CELLS; HETEROCYCLIC COMPOUNDS; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 77958472997     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720110793360595     Document Type: Article

References (27)

1. Verma, S.; Anderson, T.J. Fundamentals of endothelial function for the clinical cardiologist. Circulation, 2002, 105, 2332-2336.
2. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; Van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275, 964-967.
3. Heil, M.; Eitenmüller, I.; Schmitz-Rixen, T.; Schaper, W. Arteriogenesis versus angiogenesis: similarities and differences. J. Cell. Mol. Med., 2006, 10, 45-55.
4. Lapidot, T.; Petit, I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol., 2002, 30, 973-981.
5. Hattori, K.; Heissig, B.; Tashiro, K.; Honjo, T.; Tateno, M.; Shieh, J.H.; Hackett, N.R.; Quitoriano, M.S.; Crystal, R.G.; Rafii, S.; Moore, M.A. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood, 2001, 97, 3354-3360.
6. Kawamoto, A.; Losordo, D.W. Endothelial progenitor cells for cardiovascular regeneration. Trends. Cardiovasc. Med., 2008, 18, 33-37.
7. Bleul, C.C.; Farzan, M.; Choe, H.; Parolin, C.; Clark-Lewis, I.; Sodroski, J.; Springer, T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 1996, 382, 829-833.
8. Oberlin, E.; Amara, A.; Bachelerie, F.; Bessia, C.; Virelizier, J.L.; Arenzana-Seisdedos, F.; Schwartz, O.; Heard, J.M.; Clark-Lewis, I.; Legler, D.F.; Loetscher, M.; Baggiolini, M.; Moser, B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature, 1996, 382, 833-835.
9. Yin, Y.; Huang, L.; Zhao, X.; Fang, Y.; Yu, S.; Zhao, J.; Cui, B. AMD3100 mobilizes endothelial progenitor cells in mice, but inhibits its biological functions by blocking an autocrine/paracrine regulatory loop of stromal cell derived factor-1 in vitro. J. Cardiovasc. Pharmacol., 2007, 50, 61-67.
10. Foresta, C.; Lana, A.; Cabrelle, A.; Ferigo, M.; Caretta, N.; Garolla, A.; Palù, G.; Ferlin, A. PDE-5 inhibitor, Vardenafil, increases circulating progenitor cells in humans. Int. J. Impot. Res., 2005, 17, 377-380.
11. Foresta, C.; Ferlin, A.; De Toni, L.; Lana, A.; Vinanzi, C.; Galan, A.; Caretta, N. Circulating endothelial progenitor cells and endothelial function after chronic tadalafil treatment in subjects with erectile dysfunction. Int. J. Impot. Res., 2006, 18, 484-488.
12. Foresta, C.; Caretta, N.; Lana, A.; De Toni, L.; Biagioli, A.; Vinanzi, C.; Ferlin, A. Relationship between vascular damage degrees and endothelial progenitor cells in patients with erectile dysfunction: effect of vardenafil administration and PDE5 expression in the bone marrow. Eur. Urol., 2007, 51, 1411-1417.
13. Netherton, S.J.; Maurice, D.H. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Mol. Pharmacol., 2005, 67, 263-272.
14. Lin, C.S.; Lin, G.; Xin, Z.C.; Lue, T.F.; Expression, distribution and regulation of phosphodiesterase 5. Curr. Pharm. Des., 2006, 12, 3439-3457.
15. Guazzi, M.; Samaja, M. The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development. Curr. Med. Chem., 2007, 14, 2181-2191.
16. Foresta, C.; Caretta, N.; Lana, A.; De Toni, L.; Biagioli, A.; Ferlin, A.; Garolla, A. Reduced number of circulating endothelial progenitor cells in hypogonadal men. J. Clin. Endocrinol. Metab., 2006, 91, 4599-4602.
17. Yoder, M.C.; Mead, L.E.; Prater, D.; Krier, T.R.; Mroueh, K.N.; Li, F.; Krasich, R.; Temm, C.J.; Prchal, J.T.; Ingram, D.A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 2007, 5, 1801-1809.
18. Rauscher, F.M.; Goldschmidt-Clermont, P.J.; Davis, B.H.; Wang, T.; Gregg, D.; Ramaswami, P.; Pippen, A.M.; Annex, B.H.; Dong, C.; Taylor, D.A. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation, 2003, 108, 457-463.
19. Aicher, A.; Heeschen, C.; Mildner-Rihm, C.; Urbich, C.; Ihling, C.; Technau-Ihling, K.; Zeiher, A.M.; Dimmeler, S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med., 2003, 9, 1370-1376.
20. Moore, M.A.; Hattori, K.; Heissig, B.; Shieh, J.H.; Dias, S.; Crystal, R.G.; Rafii, S. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann. N. Y. Acad. Sci., 2001, 938, 36-45.
21. Marcet-Palacios, M.; Graham, K.; Cass, C.; Befus, A.D.; Mayers, I.; Radomski, M.W. Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle. J. Pharmacol. Exp. Ther., 2003, 307, 429-436.
22. Ciani, E.; Calvanese, V.; Crochemore, C.; Bartesaghi, R.; Contestabile, A. Proliferation of cerebellar precursor cells is negatively regulated by nitric oxide in newborn rat. J. Cell. Sci., 2006, 119, 3161-3170.
23. Andoh, T.; Chiueh, C.C.; Chock, P.B. Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin peroxidase-1 during hormesis in response to oxidative stressinduced apoptosis. J. Biol. Chem., 2003, 278, 885-890.
24. Hasegawa, A.; Yasukawa, M.; Sakai, I.; Fujita, S. Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells. J. Immunol., 2001, 166, 1125-1131.
25. Zhang, Y.; Wittner, M.; Bouamar, H.; Jarrier, P.; Vainchenker, W.; Louache, F. Identification of CXCR4 as a new nitric oxideregulated gene in human CD34+ cells. Stem Cells, 2007, 25, 211-219.
26. Stellos, K.; Langer, H.; Daub, K.; Schoenberger, T.; Gauss, A.; Geisler, T.; Bigalke, B.; Mueller, I.; Schumm, M.; Schaefer, I.; Seizer, P.; Kraemer, B.F.; Siegel-Axel, D.; May, A.E.; Lindemann, S.; Gawaz, M. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation, 2008, 117, 206-215.
27. Petit, I.; Szyper-Kravitz, M.; Nagler, A.; Lahav, M.; Peled, A.; Habler, L.; Ponomaryov, T.; Taichman, R.S.; Arenzana-Seisdedos, F.; Fujii, N.; Sandbank, J.; Zipori, D.; Lapidot, T. CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and upregulating CXCR4. Nat. Immunol., 2002, 3, 687-694.